{
    "2019-08-30": [
        [
            {
                "time": "",
                "original_text": "【东吴医药】华兰生物2019年半年报点评：业绩增长符合预期，下半年流感疫苗开始销售将为公司带来业绩增量",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "业绩增长",
                        "流感疫苗",
                        "销售"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【东兴医药胡博新团队】华兰生物（002007）：业绩略低预期，期待下半年四价流感疫苗放量",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "业绩略低预期",
                        "四价流感疫苗",
                        "放量"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "月胜率指标|判断手中基金是否值得继续持有？",
                "features": {
                    "keywords": [
                        "月胜率指标",
                        "基金",
                        "持有"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "【中银医药】华兰生物-业绩增长符合预期，静待下半年流感疫苗放量",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "业绩增长",
                        "流感疫苗",
                        "放量"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【国元医药】血制品符合预期，即将进入疫苗收获季 ——华兰生物2019H1中报点评",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "血制品",
                        "疫苗",
                        "收获季"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "204股中报报喜 31股增长超1倍",
                "features": {
                    "keywords": [
                        "中报",
                        "增长",
                        "股票"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华兰生物:业绩略逊预期,期待下半年疫苗发力 盈利能力下降",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "业绩略逊预期",
                        "疫苗",
                        "盈利能力下降"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "华兰生物:血制品景气度全面提升",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "血制品",
                        "景气度提升"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业跨市场周报:从“中国新”走向“全球新”",
                "features": {
                    "keywords": [
                        "医药生物",
                        "跨市场",
                        "周报",
                        "全球新"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}